Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 55 results for "sanofi"

Sanofi and Regeneron#39;s eczema drug gets FDA approval
Money Control

Sanofi and Regeneron's eczema drug gets FDA approval

Global healthcare company Sanofi and Regeneron Pharmaceuticals today announced that the US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) injection to patients suffering from chronic and debilitating form of eczema. DNA, 19 hours ago

594 images for sanofi

Money Control, 15 hours ago
Reuters, 6 days ago
Money Control, 4 weeks ago
Reuters, 1 month ago
American Banking News, 1 month ago
WKRB News, 1 month ago
Reuters, 1 month ago
American Banking News, 1 month ago
Ticker Report, 1 month ago
American Banking News, 1 month ago

Sanofi India: Outcome of board meeting

Sanofi India has informed that the Board of Directors of the Company at its Meeting held on February 27, 2017, took note of resignation of Mr. J. Silvestre and Mr. P. Chocat as Non-Executive Directors of Company from the close of the business hours on ...
 Money Control1 month ago Sanofi India's FY16 results on Feb 27, 2017  Money Control1 month ago

Lupin in talks with Sanofi arm Zentiva to buy inhaler brand

The two companies have been negotiating a deal for the last few months and a final transaction will help Lupin sharpen its global inhalation therapy business, an investment banking source told CNBC TV18.
 Money Control3 weeks ago
Money Control

Sanofi, Boehringer Ingelheim close business swap in India

Global healthcare leader Sanofi- Synthelabo (India) and German pharmaceutical firm Boehringer Ingelheim today said they have closed business swap which involves an exchange of over 80 brands between the two companies in India.
 DNA4 weeks ago

Buy Sanofi India; target of Rs 5330: Centrum

Centrum is bullish on Sanofi India has recommended buy rating on the stock with a target price of Rs 5330 in its research report dated February 28, 2017.
 Money Control4 weeks ago Buy Sanofi India; target of Rs 5000: Motilal Oswal  Money Control4 weeks ago
Money Control

Sanofi India Q4 net declines 58 pc to Rs 50.5 cr

Drug firm Sanofi India today reported a 57.98 per cent decline in net profit at Rs 50.5 crore for the fourth quarter ended December 2016 on account of higher expenses. The company had reported a net profit of Rs 120.2 crore in the same period a year ago, ...
 Business Standard1 month ago Sanofi India Q4 net declines 58% to Rs 50.5 cr  Money Control4 weeks ago

FIPB clears 6 FDI proposals worth Rs 1,187 cr

Inter-ministerial body FIPB today approved six investment proposals, including that of Sanofi Synthelabo India, Star Den Media Services and Idea Cellular Infrastructure Services, envisaging foreign investments of Rs 1,186.5 crore. Of the total, Recipharm ...
 Business Standard2 months ago Sanofi among six FDI proposals worth ₹1,186.5 crore cleared  Business Line2 months ago

Deals of the day-Mergers and acquisitions

(Adds PepsiCo, Sanofi, Kotak Mahindra, Exxaro Resources) March 8 (Reuters) - The following bids, mergers,acquisitions and disposals were reported by 1430 GMT onWednesday: ** South African diversified miner Exxaro Resourceswill sell its 44 percent stake in ...
 Sify3 weeks ago
Reuters

Sanofi & Lonza to jointly set up $ 285-mn biologics production facility

The facility, to be built in Switzerland, is expected to be fully operational by 2020 BS B2B Bureau | Paris, France February 27, 2017 Last Updated at 14:56 IST Sanofi and Lonza have entered into a strategic partnership to build and operate a large-scale ...
 Business Standard1 month ago Sanofi and Lonza to build new $285 million Swiss biologics facility  Reuters1 month ago Drugmaker Ipsen to buy some products from Sanofi for 83 million euros  Reuters1 month ago

UPDATE 1-Sanofi, Novo Nordisk and Lilly named in patients' price fixing suit

Three of the biggest makers of diabetes treatments, Sanofi SA, Novo Nordisk and Eli Lilly & Co, were named in a class action lawsuit about price fixing filed by a group of patients. The suit, filed on Monday in a federal court in Massachusetts, said the ...
 DNA1 month ago UPDATE 2-Sanofi, Novo Nordisk and Lilly named in patients' price fixing suit  DNA1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less